ValiRx appoints interim CSO to drive drug discovery efforts
Drug Discovery World
OCTOBER 4, 2022
Life science company ValiRx has appointed Dr Cathy Tralau-Stewart as its interim Chief Scientific Officer (CSO) to help bolster its drug discovery and therapeutic expertise. ValiRx is focused on early-stage cancer therapeutics and women’s health. .
Let's personalize your content